Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Frankfurt - Delayed Quote EUR

Zoetis Inc. (ZOE.F)

Compare

152.84

+2.96

+(1.97%)

At close: February 21 at 9:55:02 PM GMT+1

2 Healthcare Stocks with Big Upside and 1 to Skip

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 1.7% over the last six months. This drawdown is a stark contrast from the S&P 500’s 9% gain.

StockStory 21 hours ago

REGN

ZTS

MRK
Stock Markets Are Wowed By China’s AI. Alibaba, DeepSeek, Others Remain Risky Bets and 5 Other Things to Know Today.

Walmart’s outlook stokes concern about consumer spending, Buffett to address key Berkshire questions in annual letter, and more news to start your day.

Barrons.com 22 hours ago

BABA

WMT

META
Zoetis Inc. (NYSE:ZTS) Delivered A Better ROE Than Its Industry

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. 23 hours ago

ZTS
Soaring Egg Prices Reignite Debate Over Bird Flu Vaccinations

Egg companies want the government to approve treatment for use on farms, but poultry producers are wary of the economic toll.

The Wall Street Journal 23 hours ago

ZTS

PPC

TSN
Zoetis to Participate in Upcoming Investor Conferences

PARSIPPANY, N.J., February 20, 2025--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences.

Business Wire yesterday

ZTS
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks

Every stock tells a story; it takes humans to find the meaning in it.

Motley Fool 2 days ago

AAPL

CPRT

ZTS
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens

On Friday, the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE:ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens. The conditional license was granted on the demonstration of safety, purity, and reasonable expectation of efficacy based on serology data. Zoetis is committed to supporting poultry producers with scientific solutions for Highly Pathogenic Avian Influenz

Benzinga 3 days ago

ZTS
Why Zoetis Inc. (ZTS) Is Among the Best Drug Stocks to Buy Now

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against other best drug stocks to buy now. Is China the Next Big Thing in the Pharmaceutical Industry? Large American pharmaceutical companies are showing a […]

Insider Monkey 5 days ago

ZTS
2.9% earnings growth over 3 years has not materialized into gains for Zoetis (NYSE:ZTS) shareholders over that period

As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...

Simply Wall St. 5 days ago

ZTS
Why Zoetis Stock Took Another Tumble Today

One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (NYSE: ZTS) shares again tumbled. Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. Among the more influential companies wielding the scissors were white-shoe investment bank Morgan Stanley and Bank of America Securities.

Motley Fool 7 days ago

ZTS

^GSPC
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus

PARSIPPANY, N.J., February 14, 2025--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labelled for use in chickens. The conditional license was granted on the demonstration of safety, purity, and reasonable expectation of efficacy based on serology data.

Business Wire 7 days ago

ZTS
Zoetis Inc (ZTS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations

Zoetis Inc (ZTS) reports robust financial performance with significant growth in companion animal products and strategic plans for future innovation.

GuruFocus.com 8 days ago

ZTS
Q4 2024 Zoetis Inc Earnings Call

Q4 2024 Zoetis Inc Earnings Call

Thomson Reuters StreetEvents 8 days ago

ZTS
Here's What Investors Are Missing In Zoetis' Disappointing 2025 Guidance

Zoetis stock plunged Thursday after the company's 2025 guidance missed forecasts, though fourth-quarter metrics beat.

Investor's Business Daily 8 days ago

ZTS
Why Zoetis (ZTS) Shares Are Falling Today

Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported disappointing fourth-quarter results: its full-year EPS and revenue guidance fell short of Wall Street's estimates. Revenue grew 5% year over year, as weakness in livestock sales, which declined due to the divestiture of certain products, was partly offset by strength in the companion animal segment. Looking ahead, Zoetis expects 6% to 8% organic operational revenue growth, but foreign

StockStory 8 days ago

ZTS
Why Zoetis Stock Was Falling Today

Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short in its fourth quarter. Zoetis' revenue rose 5% in the quarter to $2.32 billion, edging out the consensus at $2.3 billion. Growth was balanced between the U.S. and international segments with U.S. revenue growth up 4% and international up 6%.

Motley Fool 8 days ago

ZTS
Zoetis (ZTS) Q4 2024 Earnings Call Transcript

ZTS earnings call for the period ending December 31, 2024.

Motley Fool 8 days ago

ZTS
Zoetis Stock Down Despite Q4 Earnings & Revenues Beat Estimates

ZTS stock falls despite better-than-expected fourth-quarter results due to a weak 2025 outlook.

Zacks 8 days ago

ZTS
Zoetis (ZTS) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Zoetis (ZTS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 8 days ago

ZTS
Zoetis (ZTS) Tops Q4 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 2.19% and 0.68%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 8 days ago

ZTS

Performance Overview

Return	ZOE.F	S&P 500
YTD	-2.27%	+2.24%
1-Year	-10.95%	+20.70%
3-Year	-4.64%	+38.27%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Zoetis Inc. (ZOE.F)

2 Healthcare Stocks with Big Upside and 1 to Skip

Stock Markets Are Wowed By China’s AI. Alibaba, DeepSeek, Others Remain Risky Bets and 5 Other Things to Know Today.

Zoetis Inc. (NYSE:ZTS) Delivered A Better ROE Than Its Industry

Soaring Egg Prices Reignite Debate Over Bird Flu Vaccinations

Zoetis to Participate in Upcoming Investor Conferences

Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks

Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens

Why Zoetis Inc. (ZTS) Is Among the Best Drug Stocks to Buy Now

2.9% earnings growth over 3 years has not materialized into gains for Zoetis (NYSE:ZTS) shareholders over that period

Why Zoetis Stock Took Another Tumble Today

Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus

Zoetis Inc (ZTS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations

Q4 2024 Zoetis Inc Earnings Call

Here's What Investors Are Missing In Zoetis' Disappointing 2025 Guidance

Why Zoetis (ZTS) Shares Are Falling Today

Why Zoetis Stock Was Falling Today

Zoetis (ZTS) Q4 2024 Earnings Call Transcript

Zoetis Stock Down Despite Q4 Earnings & Revenues Beat Estimates

Zoetis (ZTS) Reports Q4 Earnings: What Key Metrics Have to Say

Zoetis (ZTS) Tops Q4 Earnings and Revenue Estimates

Performance Overview